These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Therapy of hepatitis C virus-associated glomerulonephritis: current approaches. Fabrizi F; Lunghi G; Messa P; Martin P J Nephrol; 2008; 21(6):813-25. PubMed ID: 19034865 [TBL] [Abstract][Full Text] [Related]
27. Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis. Roccatello D; Baldovino S; Rossi D; Mansouri M; Naretto C; Gennaro M; Cavallo R; Alpa M; Costanzo P; Giachino O; Mazzucco G; Sena LM Nephrol Dial Transplant; 2004 Dec; 19(12):3054-61. PubMed ID: 15494358 [TBL] [Abstract][Full Text] [Related]
28. ANCA-positive pauci-immune rapidly progressive glomerulonephritis and the nephrotic syndrome. Jabur WL; Saeed HM Saudi J Kidney Dis Transpl; 2010 May; 21(3):526-30. PubMed ID: 20427883 [TBL] [Abstract][Full Text] [Related]
29. Cryoglobulinaemia type III with severe neuropathy and immune complex glomerulonephritis: remission after plasmapheresis and rituximab. Braun A; Neumann T; Oelzner P; Hein G; Gröne HJ; Ziemer M; Wolf G Rheumatol Int; 2008 Mar; 28(5):503-6. PubMed ID: 17924113 [TBL] [Abstract][Full Text] [Related]
30. Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis. Sinico RA; Di Toma L; Radice A Autoimmun Rev; 2013 Feb; 12(4):477-82. PubMed ID: 22921791 [TBL] [Abstract][Full Text] [Related]
31. Rituximab treatment for a patient with type I cryoglobulinemic glomerulonephritis. Pandrangi S; Singh A; Wheeler DE; Rossi NF Nat Clin Pract Nephrol; 2008 Jul; 4(7):393-7. PubMed ID: 18493239 [TBL] [Abstract][Full Text] [Related]
32. [Controversial issues in the Giornale Italiano di Nefrologia: how to treat patients with focal segmental glomerular sclerosis]. Passerini P; Scolari F; Frasca' GM; Leoni A; Venturelli C; Dallera N; Ravera S; Balestra E; Freddi P; Fanciulli E; D'Arezzo M; Sagripanti S G Ital Nefrol; 2009; 26(5):563-76. PubMed ID: 19802802 [TBL] [Abstract][Full Text] [Related]
33. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab. Stasi R; Stipa E; Del Poeta G; Amadori S; Newland AC; Provan D Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482 [TBL] [Abstract][Full Text] [Related]
34. Rituximab in the treatment of anti-neutrophil cytoplasm antibody-associated vasculitis. Jones RB Nephron Clin Pract; 2014; 128(3-4):243-9. PubMed ID: 25401382 [TBL] [Abstract][Full Text] [Related]
35. Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids. Quartuccio L; Soardo G; Romano G; Zaja F; Scott CA; De Marchi G; Fabris M; Ferraccioli G; De Vita S Rheumatology (Oxford); 2006 Jul; 45(7):842-6. PubMed ID: 16418196 [TBL] [Abstract][Full Text] [Related]
36. S2. Rituximab for ANCA-associated vasculitis: the UK experience. Jayne D Presse Med; 2013 Apr; 42(4 Pt 2):532-4. PubMed ID: 23490639 [No Abstract] [Full Text] [Related]